The Effect of Lacosamide in Peripheral Neuropathic Pain
The Effect of Lacosamide in Peripheral Neuropathic Pain: a Randomized, Double-blind, Placebo Controlled, Phenotype-stratified Study
Sponsor: Danish Pain Research Center
Terminated
COVID 19 and recruitment problems
Listed as NCT03777956, this PHASE2 trial focuses on Neuropathic Pain and Neuropathy and remains terminated or withdrawn. Sponsored by Danish Pain Research Center, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Mar 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Sep 2021 — Mar 2023 [monthly]
Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2
▶ Show 2 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jan 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Danish Pain Research Center
- Odense University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .